journal article·2021-02

MMP‐2 Responsive Unidirectional Hydrogel‐Electrospun Patch Loading TGF‐β1 siRNA Polyplexes for Peritendinous Anti‐Adhesion

Chuandong Cai, Wei Wang, Jing Liang, Yuange Li, Mingkuan Lu, Wenguo Cui, Cunyi Fan, Lianfu Deng, Yusheng Li, Fei Wang, Shen Liu

Advanced Functional Materials· Volume 31· Issue 6
Publisher page

Abstract

Abstract Bio‐derived hydrogel patch systems exhibit promising potential in localized drug delivery for the prevention and treatment of various diseases. However, the uncontrolled release from the hydrogel patch both in time and space, is not an optimal strategy for peritendinous anti‐adhesion, leading to transient effect and unnecessary diffusion of therapeutics. Here, an innovative composite anti‐adhesion patch is designed for on‐demand and unidirectional polyplexes delivery to inhibit fibroblasts proliferation and collagen deposition by silencing fibrosis gene transforming growth factor‐β1 (TGF‐β1). Firstly, a metalloproteinase‐2 (MMP‐2) degradable hydrogel is prepared by crosslinking allyl glycidyl ether (AGE) modified carboxymethyl chitosan (CMCS‐AGE) with MMP‐2 substrate peptide CPLGLAGC (MMP‐2 sp). Then, the hydrogel loading TGF‐β1 siRNA polyplexes are attached onto polycaprolactone (PCL) electrospun fibers to form a composite bilayer patch. The hydrogel–electrospun fibers (H–E) patch shows MMP‐2‐responsive and unidirectional release behaviors of encapsulated TGF‐β1 siRNA polyplexes and associated gene silencing effect on TGF‐β1, leading to the inhibition of fibroblasts proliferation. Moreover, after implanting the H–E patch by wrapping the repaired tendon, the formation of adhesion tissue is responsively attenuated in MMP‐2 overexpression microenvironment. This study presents a promising approach employing a composite bilayer patch with on‐demand and unidirectional delivery strategy for peritendinous anti‐adhesion.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · RNA Interference and Gene Delivery · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopaedics Shanghai Jiao Tong University Affiliated Sixth People's Hospital Shanghai 200233 China

Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases Shanghai Institute of Traumatology and Orthopaedics Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200025 China

Department of Orthopaedics National Clinical Research Center for Geriatric Disorders Central South University Xiangya Hospital Changsha 410008 China

Funding

National Natural Science Foundation of China · Shanghai Jiao Tong University · Science and Technology Commission of Shanghai Municipality

References (58)

Show source-provided references
1. 10.1016/j.addr.2019.10.00410.1016/j.addr.2019.10.004 ↗
2. 10.1016/j.biomaterials.2018.10.04110.1016/j.biomaterials.2018.10.041 ↗
3. 10.1002/adma.20170423510.1002/adma.201704235 ↗
4. 10.1126/sciadv.aba431110.1126/sciadv.aba4311 ↗
5. 10.1016/j.matt.2020.04.02210.1016/j.matt.2020.04.022 ↗
6. 10.1126/scitranslmed.aay238010.1126/scitranslmed.aay2380 ↗
7. 10.1097/PRS.000000000000604810.1097/PRS.0000000000006048 ↗
8. 10.1016/j.biomaterials.2015.05.01210.1016/j.biomaterials.2015.05.012 ↗
9. 10.1016/j.actbio.2018.01.04710.1016/j.actbio.2018.01.047 ↗
10. Wang W. · Ther. Adv. Chronic Dis. · 2020 · 11 · 204062232094477
11. 10.1002/adma.20190290010.1002/adma.201902900 ↗
12. 10.1021/acsnano.7b0815210.1021/acsnano.7b08152 ↗
13. 10.1002/jor.2076910.1002/jor.20769 ↗
14. 10.1126/science.aan467210.1126/science.aan4672 ↗
15. 10.1126/scitranslmed.aaw156510.1126/scitranslmed.aaw1565 ↗
16. 10.1038/s41551-018-0284-010.1038/s41551-018-0284-0 ↗
17. 10.1038/nrg397810.1038/nrg3978 ↗
18. 10.1126/scitranslmed.aay106310.1126/scitranslmed.aay1063 ↗
19. 10.1038/cddis.2017.13510.1038/cddis.2017.135 ↗
20. 10.1016/j.omtn.2020.07.03210.1016/j.omtn.2020.07.032 ↗
21. 10.1007/s10555-017-9717-610.1007/s10555-017-9717-6 ↗
22. 10.1038/nrg376310.1038/nrg3763 ↗
23. 10.1016/j.ijpharm.2018.05.04510.1016/j.ijpharm.2018.05.045 ↗
24. 10.1021/acs.biomac.7b0056710.1021/acs.biomac.7b00567 ↗
25. 10.1016/j.jconrel.2017.06.02010.1016/j.jconrel.2017.06.020 ↗
26. 10.1016/j.biomaterials.2014.08.02810.1016/j.biomaterials.2014.08.028 ↗
27. Wang Z. · Adv. Ther. · 2020 · 2000096
28. 10.1002/advs.20180121710.1002/advs.201801217 ↗
29. 10.1039/C5CS00586H10.1039/C5CS00586H ↗
30. 10.3389/fbioe.2020.0044510.3389/fbioe.2020.00445 ↗
31. 10.1038/gt.2015.9710.1038/gt.2015.97 ↗
32. 10.1016/j.msec.2020.11091710.1016/j.msec.2020.110917 ↗
33. 10.1038/nrneph.2016.4810.1038/nrneph.2016.48 ↗
34. 10.1002/hep.2631510.1002/hep.26315 ↗
35. 10.1016/j.carbpol.2020.11643310.1016/j.carbpol.2020.116433 ↗
36. 10.1016/j.biomaterials.2014.08.01410.1016/j.biomaterials.2014.08.014 ↗
37. 10.1016/j.biomaterials.2018.07.02210.1016/j.biomaterials.2018.07.022 ↗
38. 10.1038/nrd230910.1038/nrd2309 ↗
39. 10.1021/ar700233610.1021/ar7002336 ↗
40. 10.1016/j.cbi.2018.07.00810.1016/j.cbi.2018.07.008 ↗
41. 10.1007/978-3-319-98788-0_710.1007/978-3-319-98788-0_7 ↗
42. 10.3389/fcell.2020.0012310.3389/fcell.2020.00123 ↗
43. 10.1136/annrheumdis-2014-20574010.1136/annrheumdis-2014-205740 ↗
44. Eghbali M. · Basic Res. Cardiol. · 1992 · 87 · 183
45. 10.1002/jcp.2470710.1002/jcp.24707 ↗
46. 10.1002/jor.2217710.1002/jor.22177 ↗
47. 10.1002/jcb.2744110.1002/jcb.27441 ↗
48. Tang X. M. · Mol. Med. Rep. · 2019 · 20 · 205
49. 10.1371/journal.pone.020581110.1371/journal.pone.0205811 ↗
50. 10.2147/IJN.S16982510.2147/IJN.S169825 ↗
51. 10.1016/j.actbio.2018.03.04410.1016/j.actbio.2018.03.044 ↗
52. 10.1016/j.msec.2015.12.02810.1016/j.msec.2015.12.028 ↗
53. 10.3390/ijms1402436110.3390/ijms14024361 ↗
54. 10.1016/j.jhsa.2014.05.00510.1016/j.jhsa.2014.05.005 ↗
55. 10.1016/j.hcl.2014.12.00410.1016/j.hcl.2014.12.004 ↗
56. 10.5435/JAAOS-D-16-0031610.5435/JAAOS-D-16-00316 ↗
57. 10.1097/00000637-200045010-0001710.1097/00000637-200045010-00017 ↗
58. 10.1002/adma.20180495010.1002/adma.201804950 ↗